Mahmoodreza Khoonsari

Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Haleh Chehrehgosha, Masoudreza Sohrabi, Faramarz Ismail‐Beigi et al. · Diabetes Therapy · 2021 · 169 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Prevalence of colorectal adenoma in an average-risk population aged 40–50 versus 50–60 years

Gholamreza Hemmasi, Masoudreza Sohrabi, Farhad Zamani et al. · European Journal of Cancer Prevention · 2014 · 43 citations

Medicine, Clinical Sciences, Oncology +17

Clinical Manifestations and Diagnosis of Non-Alcoholic Fatty Liver Disease

Mahmoodreza Khoonsari, Mohammad Reza Mohammad Hoseini Azar, Ramak Ghavam et al. · Iranian journal of pathology · 2017 · 42 citations · Full text

Medicine, Internal Medicine, Pathology +17

SARS-CoV-2 Molecular and Phylogenetic analysis in COVID-19 patients: A preliminary report from Iran

Alireza Tabibzadeh, Farhad Zamani, Azadeh Laali et al. · Infection Genetics and Evolution · 2020 · 30 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study

Nima Motamed, Mehdi Nikkhah, Mohammad Hadi Karbalaie Niya et al. · Clinics and Research in Hepatology and Gastroenterology · 2021 · 23 citations

Medicine, Internal Medicine, Pathology +14